09 Jul Health Catalyst Announces Agreement to Acquire healthfinch
SALT LAKE CITY, July 09, 2020 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has entered into a definitive agreement to acquire healthfinch, Inc., a Madison, Wisconsin-based company that provides a workflow integration engine delivering insights and analytics into EMR workflows to automate physicians’ ability to close patient care gaps in real-time. The healthfinch acquisition, which will allow Health Catalyst’s customers to enhance clinical workflows in the EMR, further strengthens the Health Catalyst Population Health portfolio, which was bolstered by the Able Health acquisition in February 2020 and Care Management Suite launch earlier this month.
Within the Health Catalyst analytics application portfolio, healthfinch will be a new application suite category called EMR Embedded Insights and its refills, care gaps closure, and visit planning applications will continue to be available in their original configuration. Additionally, the healthfinch technology will augment workflows across Health Catalyst’s product portfolio, with data and insights powered by Health Catalyst’s cloud-based Data Operating System (DOS™), a healthcare-specific, open, flexible, and scalable data platform that provides customers with a single comprehensive environment to integrate and organize data.
healthfinch’s industry leading capabilities are already in demand from Health Catalyst customers and prospects across multiple product areas including quality measures, care management, population health, patient safety and others. Providing these capabilities will bring even greater value to Health Catalyst customers by making the critical insights and analytics from the DOS platform actionable within clinical workflows – providing more effective care for patients and saving time for both doctors and staff through automation so they can work at the top of their license.
Sorry, the comment form is closed at this time.